Paris, France — 10 June 2019 — Genèse Labs has been founded in Paris as an aesthetic company built on a single conviction: that the next generation of aesthetic products will be defined not by clinical performance alone, but by the completeness of regulatory compliance and verifiable scientific evidence.

Choosing Paris was a deliberate decision rather than a matter of prestige. As the historic centre of European cosmetic science and a focal point of EU beauty-industry regulation, the city offered direct access to the standards, research infrastructure, and clinician networks that would shape the company’s trajectory from the outset.

— Genèse Labs, Founding statement

Being based in France meant that every product intended for the European market would from the beginning follow a defined path: a safety assessment, a designated Responsible Person within the EU, and the prescribed notification procedures. Genèse Labs treated these requirements not as barriers to entry but as principles of product design, developing formulations to satisfy regulatory standards from the start rather than retrofitting them afterward. This early orientation carried through to the CE, CPNP and KFDA milestones that followed, and became a lasting competitive advantage.

In its early years Genèse Labs operated as a supplier, distributing aesthetic products across selected regions of Europe. That period yielded direct observation of what clinical practice actually required. Feedback gathered from dermatologists, aesthetic physicians and clinic operators across several countries revealed a consistent gap in the market — particularly in the regenerative and collagen-stimulating segment, and in body contouring. These observations became the starting point for what would later become the RG60®, Proluma™, Citrus Bottle™ and Exoluma™ product families.

At the time, the global aesthetics market was undergoing a structural transition, as demand began to move from volume correction toward biostimulation and tissue regeneration. Genèse Labs set out to position itself ahead of that shift, building a company designed to meet the standards of the future rather than the conventions of the moment.

Genèse Labs is a Paris-founded aesthetic company dedicated to science-based, regulatory-led product development across the fast-growing fields of body contouring, collagen biostimulation, and regenerative skincare. Since its foundation in 2019, the company has built its portfolio — including RG60®, Proluma™, Citrus Bottle™ and the Exoluma™ series — on three principles: scientifically verifiable formulations, regulatory compliance in every market entered, and continuous engagement with the international clinical and academic community. Genèse Labs partners with dermatologists, aesthetic physicians, and distributors worldwide to advance the standard of modern aesthetic medicine. For more information: www.geneselabs.net.